20
VI. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 13.-16-9-2007, Brijuni DARIJA STRAH Diagnostic Centre Strah, Domžale MAJA POHAR - PERME Institute for Biostatistics and Medical Informatics, Faculty of Medicine, University of Ljubljana KSENIJA GERŠAK Department of Obstetrics and Gynecology, University Medical Centre Ljubljana FIRST TRIMESTER SCREENING FOR TRISOMY 21 BY MATERNAL AGE, FETAL NUCHAL TRANSLUCENCY AND NASAL BONE IN 13.049 UNSELECTED PREGNANCIES IN SLOVENIA

DARIJA STRAH Diagnostic Centre Strah, Domžale MAJA POHAR - PERME

  • Upload
    marnie

  • View
    71

  • Download
    0

Embed Size (px)

DESCRIPTION

DARIJA STRAH Diagnostic Centre Strah, Domžale MAJA POHAR - PERME Institute for Biostatistics and Medical Informatics, Faculty of Medicine, University of Ljubljana KSENIJA GERŠAK Department of Obstetrics and Gynecology, University Medical Centre Ljubljana. - PowerPoint PPT Presentation

Citation preview

Page 1: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

VI. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 13.-16-9-2007, Brijuni 

DARIJA STRAHDiagnostic Centre Strah, Domžale

MAJA POHAR - PERMEInstitute for Biostatistics and Medical Informatics, Faculty of Medicine,University of Ljubljana

KSENIJA GERŠAKDepartment of Obstetrics and Gynecology, University Medical Centre Ljubljana

FIRST TRIMESTER SCREENING FOR TRISOMY 21 BY

MATERNAL AGE, FETAL NUCHAL TRANSLUCENCY AND

NASAL BONE IN 13.049 UNSELECTED PREGNANCIES IN

SLOVENIA

Page 2: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

VIII. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 8.-11.-9.-2011, Brijuni

Prenatal screening programs provide information with which couples can make appropriate decisions, rather than focusing on disabilities and their eradications.

(Royal College of Obstetricians and Gynaecologists, 1977)

Definition

Page 3: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

VIII. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 8.-11.-9.-2011, Brijuni  

The natural frequency of chromosomal abnormalities at birth in the absence of any prenatal diagnosis is 6 / 1.000 births.

Aneuploidies are the most frequent: T 21: 1 IN 800 (Hook, 1992) T 18: 1 IN 6.500 T 13: 1 IN 12.500.

Sex aneuplodies: Turner sy (45, x0), Klinefelter sy (47, xxy),

triploidy type I (diandry) and type II (digyny).

Incidence I

Page 4: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

VIII. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 8.-11.-9.-2011, Brijuni

Age dependent - due to shift to women having babies at an older age the general prevalence for T 21 from 1 in 740 (1974) to 1 in 504 (1997) (Egan et al., 2000).

The actual frequency changes with gestational age and intrauterine lethality of various aneuploidies. T 21: 40 % fetal loss 12. W term 30 % fetal loss 16. W term

T 18,13: 80 % fetal loss 12. W term 40 % fetal loss 16. W term (Snijders et al.,1995)

Incidence II

Page 5: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

VIII. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 8.-11.-9.-2011, Brijuni 

Screening for T21 has become an established part of obstetric practise over last 20 years by second trimester maternal serum biochemical markers. (Spencer, 1999; Cuckle, 2000; Muller et al., 2002; Wald, 2003)

AFP, free -hCG, unconjugated ESTRIOL, inhibin A; DR: 60 – 70 % at 5 % FPR (Nicolaides KH, 2004)

First trimester combined prospective screening:DR: 88 % at 5 % FPR (Nicolaides KH, 2005, Malone, 2005, O'Leary et al., 2006, Wright at al, 2008, Kagan KO et al, 2008)

Second trimester screening

Page 6: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

VIII. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 8.-11.-9.-2011, Brijuni

First trimester screening

Earlier reassurance:

- Higher detection rate (Nicolaides, 2005, 2011, Malone, 2005, O'Leary et al., 2006)

- Lower invasive testing rate (Tabor, 2008)

- Termination is safer earlier (Lawson et al., 1994)

Page 7: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

VIII. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 8.-11.-9.-2011, Brijuni

OSCAR Clinic: contemporaneous approach - one stop Clinic (Bindra et al., 2002, Avgidou et al., 2005, Nicolaides et al., 2005, Tabor 2007)

Concurrent testing: biochemistry available after US, counselling delayed (Czech Republic, Germany, Italy, Finland, Slovenia, Stenhouse et al., 2004)

Sequential testing: biochemistry taken before, counselling on the day of US (Borell et al., 2004), DR blood at 9 -10 w

Two stage testing: biochemistry taken if risk > 1/1.000 (Kagan KO, 2010)

First trimester screening modes

Page 8: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

VIII. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 8.-11.-9.-2011, Brijuni

NT is the single most effective marker for fetal aneuploidy evaluated by Mahalanobis distance – relative clinical effectiveness.

Mahalanobis distance =

Markers in discriminating normal pregnancies and T 21 in the first trimester:

NT 11,00

PAPP-A 2,48

Free -hCG 1,74

Nuchal translucency - NT

2

)(

)()(

unaffectedSD

affectedmeanunaffectedmean

Page 9: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

VIII. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 8.-11.-9.-2011, Brijuni

-

First trimester screening

Additional sonographic markers:

- Nasal bone – NB,

- Tricuspid flow –TR,

- Ductus venosus flow,

- Frontomaxilary angle – FMF,

- Intracranial Translucency – IT (Spina bifida)

DR: about 95 % at 2,5 % FPR (Nicolaides KH, 2011)

Page 10: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

VIII. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 8.-11.-9.-2011, Brijuni

The nasal root depth is abnormally short in 50 % of T21 cases (Cicero et al., 2003) in the first trimester.

- Mid saggital view of the fetal profile

- Three lines: skin, tip of the nose, NB (thicker and more echogenic)

Second trimester: 65 % of T21 has an absent or short NB (charts)

Fetal Nasal bone - NB

Page 11: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

VIII. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 8.-11.-9.-2011, Brijuni  

First – stage policy of screening without biochemistry has advantages:

- Detailed examination of fetal anatomy – early diagnosis in all pregnancies,

- Reduction in the cost of screening (Nicolaides KH, 2011)

Biochemistry in subgroup with positive first – stage screening results

Sonographic screening by maternal age, NT and NB

Page 12: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

VIII. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 8.-11.-9.-2011, Brijuni

Objectives

To examine the effectiveness of first - stage screening using maternal age, NT and NB in the detection of T 21 at 11-14 weeks in a low risk obstetric population.

Page 13: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

VIII. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 8.-11.-9.-2011, Brijuni

MethodsPeriod:

January 2005 – April 2010

13.535 women: singleton pregnancies12 4/7 (11 1/7 – 14 0/7)CRL: 63 mm (45 – 83) NT: 1,7 mm (0,9 9 – 13,4)

Excluded: twin pregnancies (3,6 %)fetal deathsno follow up

Final analysis: Final analysis: 13.04913.049 women, 2 women, 299 median maternal age median maternal age (28,9 in pop) (28,9 in pop)

Page 14: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

VIII. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 8.-11.-9.-2011, Brijuni

Results 1:

45 chromosomal abnormalities 34 detected (17 T 21, 17 other)

NB present in 98,5 %%,, absent in 25 % of abnormalities

DR: 85 %% at 2,8 FPR for T 21DR: 75,6 %% at 2,8 FPR for allDR: 68 %% at 2,8 FPR for other

NT >95 c in 75 % T 21% T 21 ( (15/20)NT >95 c in 64 % other (16/25)

Page 15: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

VIII. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 8.-11.-9.-2011, Brijuni

Risk 1 : 300

Results 2:

3 % normal pregnancies85 % T 2168 % other chromosomal abnormalities

PPV T 21: 4,3 % (17/394)NPV T 21: 99,9 % (12.652/12.655)PPV other: 4,3 % (17/394)NPV other: 99,9 % (12.647/12.655)

DR T 21: 85 % (17/20)

Page 16: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

VIII. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 8.-11.-9.-2011, Brijuni

The change (lowering) of risk treshold DR of other chromosomal abnormalities.

Change would result in pregnancy loss due to FPR and invasive testing rate.

Results 3:

Page 17: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

VIII. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 8.-11.-9.-2011, Brijuni

Trend of ageing of population of pregnant women results in FPR at risk cut - off 1: 300.

DR at 2,8 % FPR adequate according to FMF standards,no change of lowering the risk limit need.

Results 4:

Page 18: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

VIII. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 8.-11.-9.-2011, Brijuni

Conclusions 1

DR for all chromosomal aneuploidies 75,6 %;%; for T 21 85 % for other chromosomal aneuploidies 68 %.

One of twelve women defined as high risk pregnancy carried a child with chromosomal aneuploidy.

NB DR from 75 % (age, NT) to 85 % at low FPR.

Page 19: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

VIII. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 8.-11.-9.-2011, Brijuni

Conclusions 2

Our first – stage screening results:

DR for T 21 compared to reference centre Fetal Medicine Foundation (FMF), London:

85 % (at 2,8 % FPR) Slovenia

85 % (at 2,7 % FPR) FMF

Page 20: DARIJA STRAH Diagnostic Centre Strah,  Domžale MAJA POHAR  -  PERME

References

• Genetics and Etiology of Down Syndrome, 2011, ISBN 978-953-307-631-7

• http://www.intechopen.com/articles/show/title/first-trimester-screening-for-tris

• omy-21-by-maternal-age-nuchal-translucency-and-fetal-nasal-bone-in

VIII. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem 8.-11.-9.-2011, Brijuni